Tsumura Co., Ltd. announced a change in the position of the President and Representative Director, Kei Sugii, scheduled for June 26, 2026, aiming to strengthen management control and accelerate decision-making.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4540","jir_company_name":"Tsumura Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4540-20260626-01.pdf","jir_short_summary":"Tsumura Co., Ltd. announced a change in the position of the President and Representative Director, Kei Sugii, scheduled for June 26, 2026, aiming to strengthen management control and accelerate decision-making.","jir_summary":"### Overview of the Executive Personnel Change\nTsumura Co., Ltd. resolved at an extraordinary Board of Directors meeting to be held on June 26, 2026, to change the position of President and Representative Director to Kei Sugii. Mr. Sugii will assume the roles of Chief Operating Officer (COO) and President of the Medical Pharmaceuticals Business, shifting from the role of President of the Medical Pharmaceuticals Business. This move aims to further enhance the management framework and enable swift decision-making. Mr. Sugii joined Mitsubishi Oil Chemical Engineering in 1994 and has held numerous positions at Accenture and within our company. The new appointment will take effect as of June 26, 2026.\n\n### Future Outlook and Corporate Strategy\nThis executive personnel change is intended to expedite management decision-making and strengthen business competitiveness. Leveraging Mr. Sugii\u2019s extensive experience is expected to accelerate initiatives in the medical pharmaceuticals business and the development of new businesses. Details of the future management policy and medium-term plans are expected to be disclosed continuously, and this will attract investor attention as part of the company's growth strategy.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#Tsumura, #ExecutiveChange, #JapanStocks","jir_key_figures":"Date of Executive Change: June 26, 2026\nNew Position: President and COO (\u517c) President of Medical Pharmaceuticals Business\nPrevious Position: President of Medical Pharmaceuticals Business","jir_meta_title":"[Tsumura] Executive Change | June 2026","jir_meta_description":"Tsumura Co., Ltd. announced an executive personnel change on June 26, 2026. The appointment of Kei Sugii as President and Representative Director aims to strengthen management and accelerate business development.","jir_og_title":"[Tsumura] Executive Personnel Change | June 2026","jir_og_description":"Tsumura announced an executive personnel change on June 26, 2026, to accelerate management decision-making and aim for business expansion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8172,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-70369","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n